samedan logo
 
 
spacer
home > ict > winter 2017 > perfect planning
PUBLICATIONS
International Clinical Trials

Perfect Planning

The cell and gene therapies being developed today have the potential to cure diseases. To make those treatments possible, another industry has to evolve: logistics. In the past two decades, gene-based clinical trials have increased by almost 500%. The global market for regenerative medicines – including cell therapies, gene/gene-modified cell therapy and tissue engineering – is poised to reach $67 billion in 2020.

While the majority of cell and gene therapies are still experimental – aimed at rare single-gene disorders – researchers hope to build on their successes to develop treatments for multi-gene disorders, including heart disease, hypertension, diabetes, arthritis and Alzheimer’s. This makes the success of clinical trials now vitally important to humanity. However, therein lies the challenge. Unlike traditional medicines, these therapies contain living cells or viral vectors that must be protected to ensure their survival and effectiveness.

Therapies that contain these materials are produced and packaged under strictly controlled conditions. They must be transported around the world and delivered on time at optimum temperature to ensure they arrive in perfect condition. This must be done regardless of weather, traffic, mechanical difficulties, staffing irregularities, customs regulations or processing delays.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Lisa Vocat is Global Content Marketing Manager at World Courier, part of AmerisourceBergen’s global specialty logistics business. She is responsible for World Courier’s content marketing strategy and thought leadership development.
spacer
Lisa Vocat
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Horizon Discovery and Fulcrum Therapeutics Form Collaboration for Novel CRISPR-Based Target Discovery in Genetic Diseases

The collaboration will utilize Horizon’s world-leading CRISPR-based screening platform to identify novel targets for regulating gene expression.
More info >>

White Papers

Utilising Big Data to Produce Faster and Cheaper Clinical Research

Medical Research Network (MRN) Limited

Recruitment and retention of patients remains the major challenge to ensuring trials run as fast as possible and give them the statistical power they are designed to produce. This is not just about getting better any more - but about stopping the deterioration of these metrics in modern clinical trials.
More info >>

 
Industry Events

BioTrinity 2018

23-25 April 2018, Novotel London West in Hammersmith

BioTrinity 2018 is taking place from 23-25 April at the Novotel London West in Hammersmith. Now in its 12th year, BioTrinity remains the leading life sciences biopartnering and investment conference in Europe, and is a must attend event for R&D companies, TTO’s and academia who are looking to meet, collaborate, partner and seek funding from Big Pharma, Investors and Associated Industry companies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement